Reduce drug prices by eliminating PBM rebates

  • The Hill | by: Robert M. Goldberg |
  • 02/15/2017
Why are pharmacy benefit management companies -the businesses that put together the drug benefits for most Americans the latest target of drug price critics? PBMs generated nearly $130 billion in rebates – essentially cash that drug companies pay PBMs to reduce the cost of their products. 
 
That’s nearly 30 percent of the $349 billion in gross revenues the drug industry generates each year. On top of that PBMs charge the sickest patients an average of 40 percent of the list price of medicines.  So why not use these rebates to reduce drug costs. 
 
The PBMs claim that $130 billion in rebates do lower drug prices for consumers.

In fact, they pass the rebates directly to insurance companies and some businesses that contract with the PBM. In turn, the health plans use their cut for anything they want.  For example, a lawsuit against Anthem claims that the insurer used billions in rebate dollars to buy back its stock in preparation for its failed merger with Cigna.

 
Sign Up for Our Email Newsletter

RECENT NEWS

Gottlieb Likely to Take On Off-Label, Predictability at the FDA

Gottlieb Likely to Take On Off-Label, Predictability at the FDA

Dr. Scott Gottlieb is the right man in the right place at the right time....  Read more

Pharmaceutical Industry Raises Issue with Cuomo's Drug Price Control Proposal

Pharmaceutical Industry Raises Issue with Cuomo's Drug Price Control Proposal

CMPI President Peter Pitts appears on NY1 News to discuss Governor Cuomo's prescription drug proposal...  Read more

U.N.'s errant prescription for drug access

U.N.'s errant prescription for drug access

The U.N.'s war on IP rights ignores the real barrier to drug access: insufficient medical infrastructure....  Read more

DRUGWONKS BLOG